Actively Recruiting
Registry for Adults With Plasma Cell Disorders (PCD's)
Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2025-11-20
2000
Participants Needed
1
Research Sites
572 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary purpose of this protocol is to create a registry of patients with plasma cell disorders (PCDs), including for example the cancer multiple myeloma (MM), who complete the assessment, previously known as a "geriatric assessment," as is outlined in this protocol. Secondary objectives include measuring the response rate to participation of patients in this study, assessing patient satisfaction with the questionnaire, and gathering information that would lend support for future research into these types of assessments in patients with PCDs. Additionally the study offers an optional blood draw to look at a genetic marker of aging called p16INK4a (IRB 15-1899, IRB 15-0244).
CONDITIONS
Official Title
Registry for Adults With Plasma Cell Disorders (PCD's)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients have an outpatient or inpatient appointment at UNC Cancer Hospitals, affiliated clinics, or participating sites for evaluation and management of a plasma cell disorder (PCD).
- Patients have a documented diagnosis of a PCD, such as monoclonal gammopathy of uncertain significance, smoldering myeloma, multiple myeloma, plasma cell leukemia, Castleman's disease, amyloidosis, light or heavy chain deposition disease, POEMS syndrome, or cryoglobulinemia.
- Age 18 years or older.
- Must consent to participate and agree to complete assessments at baseline and follow-up.
- Must be able to read and speak English.
You will not qualify if you...
- Physical or psychiatric/behavioral illnesses that the treating clinician believes would prevent successful participation in the study.
- No imaging or lab tests are required for eligibility determination.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
North Carolina Cancer Hospital
Chapel Hill, North Carolina, United States, 27599
Actively Recruiting
Research Team
N
Nicholas Mangieri
CONTACT
K
Kendall Conder
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here